R-Tech Ueno: Protocol Amendment of a Phase I Clinical Study of RK-023 for the Treatment of Hypotrichosis of the Eyelashes
7/25/2011 8:27:39 AM
TOKYO--(BUSINESS WIRE)--R-Tech Ueno (JASDAQ:4573) is pleased to announce protocol amendment of a Phase I Clinical Study of RK-023, a new compound being developed for the treatment of hypotrichosis of the eyelashes (Note). The details are given below.
comments powered by